Case Reports in Urology最新文献

{"title":"Septic Shock Immediately following Percutaneous Suprapubic Catheterization.","authors":"Cale E Leeson,&nbsp;Brianna-Lee Beaudry,&nbsp;Geoffrey R Wignall","doi":"10.1155/2021/2184866","DOIUrl":"https://doi.org/10.1155/2021/2184866","url":null,"abstract":"<p><p>Suprapubic catheterization (SPC) is considered a safe and effective procedure for long-term bladder decompression. With proper technique and appropriate patient selection, significant complications of SPC are rare. Immediate postoperative septic shock (i.e., within the first 24 hours of surgery) is rarely reported. We report a case of an 83-year-old patient who developed septic shock within one hour of suprapubic catheterization for a chronic hypotonic bladder, highlighting the importance of early recognition of complications from SPC and prompt management to ensure positive outcomes.</p>","PeriodicalId":30323,"journal":{"name":"Case Reports in Urology","volume":"2021 ","pages":"2184866"},"PeriodicalIF":0.0,"publicationDate":"2021-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426069/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39411603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Management of Groin Pain Using an Iliohypogastric Nerve Block in a Patient with Inguinal Hernia due to Persistent Müllerian Duct Syndrome.","authors":"Takanori Sekito,&nbsp;Takuya Sadahira,&nbsp;Masahiro Sugihara,&nbsp;Kohei Edamura,&nbsp;Motoo Araki,&nbsp;Yasutomo Nasu","doi":"10.1155/2021/7577632","DOIUrl":"https://doi.org/10.1155/2021/7577632","url":null,"abstract":"<p><p>Persistent Müllerian duct syndrome can cause an inguinal hernia, although this is a rare occurrence; recurrent inguinal hernias can, in turn, cause ongoing groin pain. Management of groin pain plays an important role in patients' quality of life. We present our experience with a 43-year-old man who had a 2-week history of left-sided groin pain. The patient underwent laparoscopic surgery for a left inguinal hernia via the transabdominal preperitoneal approach. Right-sided cryptorchidism was noted during surgery, with a solid structure-thought to be a uterus-extending into the left inguinal canal. The diagnosis was persistent Müllerian duct syndrome, and the groin pain was relieved after a laparoscopic right orchiectomy with a bilateral preperitoneal hernia repair using a mesh. Four years later, magnetic resonance imaging performed for new-onset left groin pain showed a left inguinal hernia caused by the uterine structure. We diagnosed the recurrent hernia as the cause of his pain. Prior to performing any invasive surgical procedures, an iliohypogastric nerve block was performed using 1% lidocaine. Short-term analgesia was provided by the block, improving his quality of life. He has been followed since then and has declined surgical neurectomy. An iliohypogastric nerve block can be an effective method of controlling groin pain caused by an inguinal hernia resulting from persistent Müllerian duct syndrome; the effectiveness of the nerve block will help determine whether surgical neurectomy is indicated for permanent pain control.</p>","PeriodicalId":30323,"journal":{"name":"Case Reports in Urology","volume":"2021 ","pages":"7577632"},"PeriodicalIF":0.0,"publicationDate":"2021-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8376460/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39337182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Ureteroarterial Fistula: A Diagnosis Which Is Not Always Black and White.","authors":"A Haffar,&nbsp;T Trump,&nbsp;A A Elbakry,&nbsp;K McCluskey,&nbsp;M W Salkini,&nbsp;A Luchey","doi":"10.1155/2021/8165991","DOIUrl":"https://doi.org/10.1155/2021/8165991","url":null,"abstract":"<p><p>Ureteroiliac artery fistulas are a rare, life-threatening condition that requires a high index of suspicion for prompt diagnosis. Presurgical diagnosis is challenging as this condition can lie hidden despite advanced imaging modalities. We present two cases of patients presenting with gross hematuria and exsanguination in the setting of a ureteroiliac artery fistula. These cases highlight the difficulties in timely diagnosis and treatment in a multidisciplinary team.</p>","PeriodicalId":30323,"journal":{"name":"Case Reports in Urology","volume":"2021 ","pages":"8165991"},"PeriodicalIF":0.0,"publicationDate":"2021-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371582/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39335145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Vulvar Pyogenic Granuloma in Adult Female Population: A Case Report and Review of the Literature.","authors":"Nastaran Mahmoudnejad,&nbsp;Alireza Zadmehr,&nbsp;Mohammad Hamidi Madani","doi":"10.1155/2021/5525092","DOIUrl":"https://doi.org/10.1155/2021/5525092","url":null,"abstract":"<p><p>Pyogenic granuloma (PG) is an uncommon lesion of unknown etiology. It may be formed following a minor injury. They result from a reactive or inflammatory process consisting of proliferating vascular channels, immature fibroblastic connective tissue, and scattered inflammatory cells rather than neoplastic process. Bleeding is the most common symptom of the lesion. They may be seen in all age groups, and there is no clear predominance of a gender. Vulvar PGs can be confused with other polypoid or sessile lesions of the genital site. There are only a few cases of female genital PGs reported in the literature. Herein, we describe the first case of vulvar (clitoral) PG in an Iranian patient and a brief review of the literature in this regard.</p>","PeriodicalId":30323,"journal":{"name":"Case Reports in Urology","volume":"2021 ","pages":"5525092"},"PeriodicalIF":0.0,"publicationDate":"2021-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357474/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39313471","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Successful Response of Pembrolizumab Rechallenge after Radiotherapy for a Patient with Bladder Cancer of Nonresponse of Pembrolizumab First Challenge.","authors":"Taro Ikeda,&nbsp;Go Hasegawa,&nbsp;Gen Kawaguchi,&nbsp;Yohei Ikeda,&nbsp;Noboru Hara,&nbsp;Tsutomu Nishiyama","doi":"10.1155/2021/9087529","DOIUrl":"https://doi.org/10.1155/2021/9087529","url":null,"abstract":"<p><p>We report a patient with advanced bladder cancer in which the primary lesion and metastatic site disappeared following the pembrolizumab therapy rechallenge after radiotherapy for bladder cancer lesion of nonresponse of pembrolizumab first challenge. A 76-year-old man with advanced bladder cancer received three courses of the chemotherapy with gemcitabine and cisplatin combination; however, the chemotherapy was stopped because of adverse events. The patient started pembrolizumab therapy; however, the effect was not observed. Radiation therapy was given to the primary lesion and pelvic lymph node metastases for the purpose of local control of the lesions. Because the primary lesion was regrowth and para-aortic lymph node metastasis appeared, pembrolizumab therapy was resumed. Thereafter, the primary lesion and metastatic site disappeared.</p>","PeriodicalId":30323,"journal":{"name":"Case Reports in Urology","volume":"2021 ","pages":"9087529"},"PeriodicalIF":0.0,"publicationDate":"2021-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8337140/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39291940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Diffuse Leukoplakia of the Bladder Ostium-Sparing in Patient Treated with Leuprorelin for Breast Cancer.","authors":"Antonio Nacchia,&nbsp;Ferdinando di Giacomo,&nbsp;Arcangelo Di Cerbo,&nbsp;Massimo Dante Di Somma,&nbsp;Giuseppe Patitucci,&nbsp;Giuseppe Disabato,&nbsp;Giulia Vita","doi":"10.1155/2021/9970711","DOIUrl":"https://doi.org/10.1155/2021/9970711","url":null,"abstract":"<p><strong>Case: </strong>A 55-year-old woman came to our attention in April 2020 referring haematuria, frequency and urgency. The patient referred previous treatment with leuprorelin 3.75 mg/2 ml for breast cancer three years ago. Urine culture was performed and resulted always negative for pathogens. Cystoscopy revealed a whitish plaque lesion on the fundus, dome, trigone, and left lateral wall of the bladder. Histology of the biopsy confirmed the diagnosis of leukoplakia of the bladder. The plan is to follow her up repeating a cystoscopy every three months and biopsy in 6 months. Literature search revealed very little information on pathogenesis and prognosis of this condition due to its rare occurrence. The main objective of our case study was to describe individual situation of a woman affected by diffuse leukoplakia of the bladder ostium-sparing with a previous treatment with leuprorelin 3.75 mg/2 ml for breast cancer and to show safety of follow-up by cystoscopy and biopsy.</p><p><strong>Conclusions: </strong>We showed a case of a woman treated with leuprorelin and with diffuse leukoplakia of the bladder. We support the recommended long-term follow-up and surveillance based on the literature review by cystoscopy with or without biopsy.</p>","PeriodicalId":30323,"journal":{"name":"Case Reports in Urology","volume":"2021 ","pages":"9970711"},"PeriodicalIF":0.0,"publicationDate":"2021-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8337129/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39291941","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Malignant Priapism as a Result of Metastatic Thyroid Cancer: A Hard Reality.","authors":"Ethan Vargo,&nbsp;Bryson Cook,&nbsp;Jason Lane,&nbsp;Eric Speakman,&nbsp;Neel Parekh","doi":"10.1155/2021/5542092","DOIUrl":"https://doi.org/10.1155/2021/5542092","url":null,"abstract":"<p><p>Metastasis to the penis is an extremely rare entity. Malignant priapism is defined as a persistent, nonsexual erection that is refractory to pharmacologic treatment, corporal aspiration, and surgical shunts. Furthermore, it is typically a hallmark of an advanced cancer that has metastasized, most commonly from regional organs like the prostate or bladder. We report an unusual case of malignant priapism in the setting of metastatic follicular thyroid carcinoma. To date, this is the second reported case of penile metastasis due to thyroid carcinoma and the first incidence of priapism secondary to follicular thyroid carcinoma metastasis.</p>","PeriodicalId":30323,"journal":{"name":"Case Reports in Urology","volume":"2021 ","pages":"5542092"},"PeriodicalIF":0.0,"publicationDate":"2021-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8337126/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39291485","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Squamous Cell Carcinoma Developing in a Buccal Mucosa Graft after Urethroplasty: A Report of 2 Cases of Malignant Degeneration.","authors":"Catti Massimo,&nbsp;Nappo Gerocarni Simona,&nbsp;Tadini Barbara,&nbsp;Cerchia Elisa,&nbsp;Ferrero Luisa,&nbsp;Gambella Alessandro,&nbsp;Pacchioni Donatella,&nbsp;Elisabetta Teruzzi,&nbsp;Marco Falcone,&nbsp;Sedigh Omidreza,&nbsp;Gontero Paolo","doi":"10.1155/2021/5569373","DOIUrl":"https://doi.org/10.1155/2021/5569373","url":null,"abstract":"<p><p>Buccal mucosa graft (BMG) was originally described in 1992 for the treatment of challenging cases of hypospadias (proximal or redo cases) and has gained increasingly popularity also when dealing with complicated urethral stenosis, as it is associated with a good outcome. The development of a malignancy in a BMG urethroplasty was reported for the first time in 2017. We report two more cases of a malignant degeneration of a BMG used in a urethroplasty to treat recurrent urethral stricture.</p>","PeriodicalId":30323,"journal":{"name":"Case Reports in Urology","volume":"2021 ","pages":"5569373"},"PeriodicalIF":0.0,"publicationDate":"2021-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8328690/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39277125","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Giant Cell Urothelial Carcinoma of Bladder.","authors":"Harshima Disvini Wijesinghe,&nbsp;Ajith Malalasekera","doi":"10.1155/2021/8021947","DOIUrl":"https://doi.org/10.1155/2021/8021947","url":null,"abstract":"<p><p>Giant cell urothelial carcinoma is a rare variant of bladder cancer recognized by the current World Health Organization classification of urologic tumours. It is an aggressive tumour with a poor prognosis that usually presents at an advanced stage. It is characterized histologically by pleomorphic giant cells. We discuss a case of giant cell urothelial carcinoma presenting at an early stage in a previously well 62-year-old woman. Histology showed a tumour comprising pancytokeratin positive bizarre mononuclear and multi-nuclear giant cells admixed with areas of conventional urothelial carcinoma and carcinoma in situ. Three-month follow-up cystoscopy and magnetic resonance imaging showed no evidence of recurrence or pelvic lymphadenopathy.</p>","PeriodicalId":30323,"journal":{"name":"Case Reports in Urology","volume":"2021 ","pages":"8021947"},"PeriodicalIF":0.0,"publicationDate":"2021-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302384/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39258531","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Effectiveness of Steroid Pulse Therapy for Systemic Side Effects after Bacillus Calmette-Guérin Intravesical Instillation Therapy: A Series of Five Cases.","authors":"Tatsuya Umemoto,&nbsp;Jun Naruse,&nbsp;Yukio Usui,&nbsp;Hidenori Zakoji,&nbsp;Hideshi Miyakita,&nbsp;Akira Miyajima","doi":"10.1155/2021/5548054","DOIUrl":"https://doi.org/10.1155/2021/5548054","url":null,"abstract":"<p><strong>Introduction: </strong>Bacillus Calmette-Guérin (BCG) instillation is an established therapy for the treatment of carcinoma in situ (CIS) of the bladder and prevention of recurrence after transurethral resection of bladder tumor noninvasive bladder cancer. However, serious systemic side effects may occur in less than 5% of patients with BCG intravesical instillation. Systemic side effects can sometimes be fatal and require early and accurate treatment. We describe five cases wherein steroid pulse therapy was effective for treating the systemic side effects after BCG intravesical instillation. <i>Case Presentations</i>. BCG intravesical instillation was used to prevent the recurrence of nonmuscle invasive bladder cancer and treat CIS of the bladder; the dose used was 40-80 mg each time, and the Tokyo strain was used. The patients developed fever, impaired consciousness, arthralgia, conjunctival hyperemia, and symptoms of cystitis. The median time from installation to side effect manifestation was 6 days (0-8). One to two courses of steroid pulse therapy were administered (1 course in 3 days), and the dose of methylprednisolone was 500-1000 mg/day. BCG sepsis was observed in one case; however, in the other four cases, one course of steroid pulse therapy showed a rapid improvement in symptoms. In the case of BCG sepsis, hemodialysis and mechanical ventilation were required because of septic shock and acute renal failure. Antituberculosis drugs (isoniazid, rifampicin, and ethambutol) were started promptly; however, no improvement was noticed. Two courses of steroid pulse therapy improved the patient's general condition, and hemodialysis and mechanical ventilation were no longer required. All patients survived without relapse of symptoms.</p><p><strong>Conclusion: </strong>Our cases suggest that early steroid pulse therapy may be effective for rapid symptom improvement of the systemic side effects of BCG instillation therapy.</p>","PeriodicalId":30323,"journal":{"name":"Case Reports in Urology","volume":"2021 ","pages":"5548054"},"PeriodicalIF":0.0,"publicationDate":"2021-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286186/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39273867","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}